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Abstract
MicroRNAs are a recently discovered class of small noncoding functional RNAs. These molecules
mediate post-transcriptional regulation of gene expression in a sequence specific manner.
MicroRNAs are now known to be key players in a variety of biological processes and have been
shown to be deregulated in a number of cancers. The discovery of viral encoded microRNAs,
especially from a family of oncogenic viruses, has attracted immense attention towards the
possibility of microRNAs as critical modulators of viral oncogenesis. The host-virus crosstalk
mediated by microRNAs, messenger RNAs and proteins, is complex and involves the different
cellular regulatory layers. In this commentary, we describe models of microRNA mediated viral
oncogenesis.
Background
Interest in the involvement of infectious agents in onco-
genic transformation, and more so viruses, has been of
historical importance, probably starting with Rous' dis-
covery of filterable particles that could transmit avian sar-
coma [1]. This was followed by the discovery of the role of
other viruses in oncogenic transformation of eukaryotic
cells. Subsequently, attempts were made to understand
the molecular mechanisms of viral oncogenesis. A new
field of noncoding RNA mediated regulation has emerged
following the discovery of microRNAs, which are ~22
nucleotide long noncoding regulatory RNAs found in
eukaryotes and viruses, and the unraveling of their critical
roles in normal and abnormal biological processes
including development, host-virus interaction and neo-
plasia [2]. These small endogenous noncoding RNAs are
derived from introns or intergenic regions in the genome,
many of which were previously thought to be 'junk DNA'.
They are processed from hairpin forming precursors by a
battery of cellular proteins. These small RNAs, in associa-
tion with a ribonucleoprotein complex termed as the RNA
Induced Silencing Complex, or RISC, mediate post-tran-
scriptional regulation of gene expression. They do this by
binding to the 3'UTR regions of the transcripts, harboring
regions of imperfect complementarity. The biogenesis and
action of microRNAs have been extensively reviewed
[3,4]. The role played by microRNAs in the defense of
mammalian cells against virus infection has also been dis-
cussed recently [5-7].
MicroRNAs constitute a hitherto unexplored layer of
genetic interactions between the virus and the host. The
regulatory impact of microRNAs is huge because a single
microRNA can regulate multiple transcripts and multiple
microRNAs can regulate a single transcript. This is very
similar to transcriptional regulatory networks. Models of
microRNA in host-virus cross-talk have been reviewed
recently [8,9]. The recent discovery of microRNAs
encoded by a number of viruses, including many human
oncogenic viruses, has attracted renewed interest in the
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molecular mechanism of viral oncogenesis. This novel
regulatory layer, mediated by microRNAs, has a far-reach-
ing impact on the latency and pathogenesis of viruses,
including the mechanism of virus induced cancers. The
molecular role of microRNAs in viral oncogenesis may be
diverse, ranging from viral encoded microRNAs to virus
encoded suppressors of RNA interference. Cancer itself is
multifactorial, wherein deregulation at multiple levels
culminates in the global regulatory derangement, thereby
making molecular oncogenesis an enigma. In this review
we discuss, in light of recent reports, the various possible
mechanisms and/or models of host-virus interactions cul-
minating in oncogenesis mediated by microRNAs. Figure
1 provides a simplistic overview of the role of microRNAs
in viral oncogenesis. Challenges in the field and future
perspectives are also discussed.
Here, we survey host-virus crosstalk culminating in onco-
genesis encompassing five major models: (1) viral micro-
RNAs and their effects, (2) viral integration and its effects
on host and viral microRNAs, (3) virus induced genetic
instabilities, (4) virus mediated suppression of RNA inter-
ference, and (5) Virus induced epigenetic changes.
Virus encoded microRNAs and their cellular targets
Recent genome-wide screens, enabled by computational
approaches and high-throughput validation, have discov-
ered 109 microRNA precursors encoded by viruses. A
major chunk of the currently known microRNAs are
encoded by the herpes virus family of viruses which
include a number of human oncogenic viruses like Herpes
Simplex virus, Kaposi Sarcoma Herpes Virus and Epstein
Barr virus. The logical question then would be: what are
the targets of these virus encoded microRNAs and what
are the physiological processes regulated by these microR-
NAs. A computational analysis of the targets of EBV
encoded microRNAs, using a consensus prediction of
three commonly used target prediction algorithms,
reveals that the transcripts targeted by these microRNAs
are over-represented in the genes associated with apopto-
sis and tumor-suppression [9]. Moreover, a majority of
these RNAs are derived from the BART and BHRF cluster
of genes, which are classically known to be activated dur-
ing latent phase of the virus [10]. This finding becomes
more relevant in light of recent evidence that suggests that
in EBV induced gastric carcinoma, the BART cluster of
microRNAs are expressed, while the BHRF cluster is not.
Model for host-virus crosstalk in viral oncogenesis Figure 1
Model for host-virus crosstalk in viral oncogenesis. The planes describe the different layers of cellular regulatory organization 
and the interconnections between different layers marked by thin lines. The arrows on the left side show the mechanisms 
where viruses or virus encoded gene products interact or interfere with host regulatory mechanism.Retrovirology 2007, 4:82 http://www.retrovirology.com/content/4/1/82
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Both together suggest an important role for the BART clus-
ter of microRNAs in EBV mediated gastric carcinomas [11]
and probably, in other cancers caused by the virus. Recent
experimental evidence on the targets of Herpes Simplex
Virus, another related Herpes virus, also shows that virus
encoded microRNAs target transcripts involved in apopto-
sis [12]. Similarly another oncogenic virus in avians,
Marek's Disease virus (MDV) has been recently shown to
encode a microRNA targeting the latency associated tran-
script and its expression in MDV induced tumors [13,14].
Computational algorithms for prediction of miRNAs' tar-
get transcripts have improved drastically over recent years.
The current state of the art computational techniques and
their application in the prediction of microRNA-targets
was reviewed by Maiere and Enright [15]. Efficient com-
putational methods, combined with high-throughput
experimental methods, have greatly facilitated the task of
miRNA and target identification. The putative functional
roles of virus encoded microRNAs are summarized in
Table 1. However, the steady increase in the number of
microRNAs encoded by viruses does not match with the
number of targets experimentally validated, which is a
deterrent towards understanding the functional role of
these microRNAs. This is primarily because rapid experi-
mental validation of computational predictions is still an
unmet challenge.
Virus integration modulating host microRNAs
Integration of the viral genome into the host and its effect
in tumorigenesis have been active areas of research in
oncology. This field has been particularly enriched by
studies of gene therapy vectors and the emergence of
transposon-mediated mutagenesis as tools to study gene
function. Viral integrations can occur non-randomly in
the host genome, with some classes of viruses showing
specific insertion patterns. Viral integration is also known
to result in short or long range effects on the expression of
host genes including genes which code for microRNAs.
Recent reports show that oncogenic microRNAs could be
up-regulated by viral integration in their vicinity [16,17].
Feitelson et al. [18]reported that in Hepatitis B induced
viral hepato-carcinogenesis a large number of viral inte-
gration events occur near or within fragile sites and/or
other cancer-associated host loci which are prone to insta-
bility or are critical for tumor development and progres-
sion [19]. Similarly, loss of miRNA function can also
occur via viral integration because some microRNAs fall
within regions disrupted by viral integration. An example
for this is hsa-mir-566, a repeat associated microRNA
which falls in a retroviral integration site (unpublished
results). This throws open a new avenue, whereby stochas-
ticity of viral integration events could differentially mod-
ulate the expression of tightly regulated factors,
culminating in neoplasia. The effect of viral integration
and the consequential modulation of gene expression,
including microRNAs and modulators of microRNA
expression, have not been explored in detail. Recent anal-
ysis of chromosomal susceptibility loci in murine cancers
has suggested the association between the locations of
mouse miRNAs and known sites of retroviral integration
in mouse cancers [20]. Computational analysis of viral
integration site libraries for microRNA genes in nearby
regions would prove to be useful in understanding viral
modulation of microRNA expression and the pathogene-
sis of viral oncogenesis. Viral transcripts could also possi-
bly modulate host microRNA expression by sequestering
microRNAs or the cell's microRNA processing machinery,
and tilting the balance of normal cellular regulation, sim-
ilar to the description of target mimicry in Arabidopsis
[21].
Virus induced genetic instabilities and errors in DNA repair
Apart from viral integration, genetic instabilities induced
by viruses have also been extensively studied. Fragile sites
and genomic instabilities, including aneuploidies, have
been of particular interest in studying mechanisms of
oncogenesis. Recent computational screens for fragile
Table 1: List of virus-encoded microRNAs and their possible functional roles.
Virus Name Family Number of microRNA precursors Functional role
Epstein Barr virus Herpesviridae 23 ? Regulation of Tumor Suppression/
Apoptosis
Herpes Simplex Virus 1 Herpesviridae 2 Regulation of Apoptosis
Human cytomegalovirus Herpesviridae 11
Kaposi sarcoma-associated herpesvirus Herpesviridae 13 Regulation of cell adhesion, migration, and 
angiogenesis
Mareks disease virus (Type 1 and 2) Herpesviridae 25 Virus-induced transformation of chicken T 
cells
Mouse gammaherpesvirus 68 Herpesviridae 9 -
Rhesus lymphocryptovirus Herpesviridae 16 -
Rhesus monkey rhadinovirus Herpesviridae 7 ? Regulation of immune response pathways
Simian virus 40 Polyomaviridae. 1 Cytotoxic T-cell escape
Human immunodeficiency virus 1 Retroviridae 2 ? Regulation of latencyRetrovirology 2007, 4:82 http://www.retrovirology.com/content/4/1/82
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chromosomal breakpoints associated with cancers,
including regions of instability induced by papillomavi-
ruses, have shown that many microRNAs including onco-
genic microRNAs lie in close proximity to regions of
chromosomal rearrangements [19]. Apart from chromo-
somal rearrangements and instability, virus-mediated
suppression of cellular DNA repair, activation of telomer-
ase and telomere maintenance have been well explored in
cancers. Examples of viral supressors of the DNA repair
mechanism include the E6 protein of Human Papilloma-
virus which down regulates the methyl guanine methyl-
transferase (MGMT) and the X protein encoded by
Hepatitis B virus, which interacts with UVDDB, a putative
DNA repair protein. Viral activation of telomerase has
been well studied in the context of KSHV where KSHV
viral associated nuclear antigen which binds to Sp1 and
transactivates telomerase expression [22]. Widespread
mutations in the host genome and their effects on micro-
RNA mediated regulation have not been actively pursued
though accounts of mutational effects on microRNAs and
target regions in the 3'UTR have emerged very recently
[23].
Virus encoded suppressors of RNAi
RNA interference has emerged as a mechanism of antiviral
defense in many plants and insects. Viruses have over-
come this by encoding for proteins that can particularly
suppress the RNAi mechanism by multiple methods rang-
ing from binding to dsRNA, to binding and disrupting
functions of key proteins involved in microRNAs process-
ing [24-26]. Such global suppressions of host microRNA
expression have been recently shown in HIV infection
studies [27]. Recently Haasnoot et al. [28] have shown
that Ebola Virus VP35 protein is a suppressor of RNAi,
akin to the function of Tat in HIV infection. This means
that suppressors of RNAi are a conserved feature in many
pathogenic viruses. Many of these mechanisms culminate
in deregulation of microRNAs biogenesis. Such global
derangement of microRNA biogenesis has been recently
shown to be oncogenic [29]. Direct evidence for virus
encoded suppressors of RNAi resulting in a global
derangement of microRNA biogenesis resulting in abnor-
mal microRNAs mediated regulation of key tumor sup-
pressors and cell cycle checkpoint genes remains to be
established. It would also be interesting to explore how
viral microRNAs modulate the cellular RNAi mechanism
to regulate viral and/cellular targets.
Virus induced epigenetic changes in the host
Epigenetic changes have recently been shown to be critical
in modulating the spatial and temporal expression pro-
files of microRNAs. Viruses, especially those involved in
oncogenesis have been extensively investigated for their
potential to modulate host epigenetic changes, including
DNA methylation, histone modification and chromatin
remodeling. Flanagan has exhaustively reviewed the dif-
ferent models of host epigenetic regulation by oncogenic
viruses [30]. The possibility of viral proteins to modulate
microRNA expression through epigenetic mechanisms
has not been thoroughly studied. Recent evidence has
substantiated an epigenetic role for viral microRNA in the
transcriptional silencing of HIV [31]. Further understand-
ing of how viral microRNAs modulate epigenetic regula-
tion would open up potential new arenas for therapy.
Virus infection modulating microRNA expression and host 
signaling
Viral infections have been shown to modulate host gene
expression in multiple ways. One major pathway used by
host cells in viral defense is the Toll-like receptor (TLR)
pathway. Viruses have the potential to activate Toll-like
receptors. TLR-pathways can trigger a cascade of down-
stream effectors, some leading to the activation of tran-
scriptional modulators such as NF kappa B which can in
turn regulate the expression of oncogenic microRNAs
[32]. It remains to be seen whether this type of virus-initi-
ated circuitry contributes substantively to the effects of
chronic viral infections which can result in cancers.
Separately, recent evidence suggests that HIV-1 infection
can significantly remodel the host cell's microRNA profile
[33]. Specifically, HIV-1 appears to down regulates a
number of antiviral microRNA genes and to up regulates
of a small number of microRNAs, including the miR-17-
92 cluster of microRNAs previously known to be involved
in oncogenesis [27]. The exact role of these microRNAs in
viral pathogenesis and/latency is not known. There is a
possibility that the functional role of the microRNAs
would be different in different cell-types due to transcript
diversity between cell types.
The way forward- understanding microRNA role in viral 
pathogenesis: a systems biology approach to host-virus 
interaction
The current understanding of the role of microRNAs in
host-virus crosstalk or viral oncogenesis is far from com-
plete. There is a need to co-ordinate efforts from multiple
experimental labs to build a holistic view of host-virus
interactions. This would include prediction and valida-
tion of genome-scale protein-protein and microRNA -tar-
get interactions, along with temporal analysis of gene
expression which could be integrated onto a bioinformat-
ics platform to understand the dynamics and intricacies of
host-virus crosstalks. Recently, a number of databases of
biological pathways and protein interactions including
host-pathogen interactions as in the case of HIV have been
developed by Reactome [34]. Similarly, there have been
consistent efforts to collect gene expression and pro-
teomic datasets in central repositories [35]. Availability of
high-throughput expression and proteomics coupled toRetrovirology 2007, 4:82 http://www.retrovirology.com/content/4/1/82
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high performance operating platforms could allow one to
integrate questions and answers in a systems biology
manner. This collective approach could greatly aid in
understanding host-virus interactions in an inclusive way.
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